IMU 5.08% 6.2¢ imugene limited

Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-80

  1. 27,145 Posts.
    lightbulb Created with Sketch. 1759
    The 12 months play was about a T/O after the timeframe of the expected significant clinical updates. IMU reported $140M in cash at the start of the year and they use around $24M per quarter with half of those expense on R&D so at that expenditure rate will use $96M end of this year with R&D rebate of $24M so will have around $58M in cash remaining.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.003(5.08%)
Mkt cap ! $455.6M
Open High Low Value Volume
5.8¢ 6.5¢ 5.7¢ $1.751M 28.44M

Buyers (Bids)

No. Vol. Price($)
6 660964 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 549788 5
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.